Correlation Between Neurocrine Biosciences and Lipocine
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Lipocine, you can compare the effects of market volatilities on Neurocrine Biosciences and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Lipocine.
Diversification Opportunities for Neurocrine Biosciences and Lipocine
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Neurocrine and Lipocine is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Lipocine go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Lipocine
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.67 times more return on investment than Lipocine. However, Neurocrine Biosciences is 1.49 times less risky than Lipocine. It trades about -0.1 of its potential returns per unit of risk. Lipocine is currently generating about -0.11 per unit of risk. If you would invest 13,706 in Neurocrine Biosciences on December 30, 2024 and sell it today you would lose (2,390) from holding Neurocrine Biosciences or give up 17.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Neurocrine Biosciences vs. Lipocine
Performance |
Timeline |
Neurocrine Biosciences |
Lipocine |
Neurocrine Biosciences and Lipocine Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and Lipocine
The main advantage of trading using opposite Neurocrine Biosciences and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |